✓ Credit card payment restored — secure checkout via Privacy Shield

Temotero

✅ Fights brain tumors
✅ Slows tumor growth
✅ Increases survival rates
✅ Oral chemotherapy option
✅ Well-tolerated treatment

Temotero contains Temozolomide.

Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience  · Last reviewed: May 2026

Buy more, save more Price per capsule
Select a strength above to see pack pricing.
Encrypted checkout
Crypto pays 10% less
Discreet worldwide delivery
1,400+ customers · 50+ countries

⚡ Quick Answer — What is Temotero?

Temotero is an oral capsule from Glenmark containing temozolomide at 20 mg and 100 mg — an oral alkylating cytotoxic agent and the standard chemotherapy for glioblastoma multiforme (GBM) and anaplastic astrocytoma. Standard regimen: concurrent with radiotherapy (75 mg/m² daily for 6 weeks), then maintenance 150–200 mg/m² daily for days 1–5 of each 28-day cycle for 6 cycles (Stupp protocol). Take on an empty stomach at the same time each day, with antiemetic (ondansetron) 1 hour before. Mandatory: PCP prophylaxis with co-trimoxazole during radiotherapy phase. FBC weekly during concurrent phase, then before each maintenance cycle.

What you get with MedsBase: WHO-GMP certified manufacturer · Discreet packaging · Worldwide shipping · 1,400+ verified customer reviews

📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.

⚠ Specialist supervision required. Cancer medications must be prescribed by a treating oncologist with a confirmed diagnosis, baseline staging, and a defined treatment plan. Never start, stop, change dose, or use cancer medication outside of an oncology-led care plan. Most cancer drugs require regular blood-test monitoring (FBC, LFT, renal function), are absolutely contraindicated in pregnancy, and have significant drug interactions.
🔒 Encrypted Checkout · 💳 Verified Processor · 🚚 Worldwide Shipping · ⭐ 4.9/5 from 1,400+ customers

What Is Temotero?

Temotero is an oral capsule from Glenmark containing temozolomide (20 mg and 100 mg). Temozolomide is an oral alkylating cytotoxic agent of the imidazotetrazine class. It crosses the blood-brain barrier (CSF concentration ~30% of plasma) and is the only oral cytotoxic with proven survival benefit in glioblastoma multiforme. Standard combination with radiotherapy (the “Stupp protocol”, 2005) extended median GBM survival from 12 months to 15 months and 2-year survival from 11% to 27%.

Uses and Indications

  • Newly-diagnosed glioblastoma multiforme (GBM) — concurrent with radiotherapy then maintenance (Stupp protocol)
  • Anaplastic astrocytoma after recurrence
  • Recurrent high-grade glioma
  • Off-label: melanoma brain metastases, neuroendocrine tumours

Dosage (Stupp protocol)

  • Concurrent phase: 75 mg/m²/day continuously during 6 weeks of radiotherapy (total ~42 days)
  • 4-week break after radiotherapy completion
  • Maintenance phase: 150 mg/m²/day for days 1–5 of a 28-day cycle (cycle 1); escalate to 200 mg/m²/day if tolerated for cycles 2–6 (total 6 cycles, with newer evidence supporting up to 12 cycles in younger MGMT-methylated patients)
  1. Take on an empty stomach at the same time each day — food slows absorption and reduces peak concentration. Most patients take it at bedtime, ≥ 2 hours after the last meal.
  2. Antiemetic: ondansetron 8 mg orally 1 hour before each temozolomide dose, especially during the maintenance phase 5-day pulse.
  3. Swallow capsules whole with water. Do NOT open or chew — powder is cytotoxic.
  4. PCP prophylaxis with co-trimoxazole 480 mg three times weekly during the concurrent phase — lymphopenia risk. Continue until CD4 > 200 cells/µL.
  5. Mandatory monitoring: FBC weekly during concurrent phase; before each maintenance cycle (day 22 of previous cycle and day 1 of each new cycle); LFTs monthly. Hold cycle for ANC < 1,500/µL or platelets < 100,000/µL.
  6. If a dose is vomited within 1 hour, do NOT re-dose. Resume next day per schedule.

Side Effects

Common: nausea, vomiting (mostly preventable with ondansetron), fatigue, anorexia, constipation, headache, alopecia.

Important:

  • Myelosuppression — especially thrombocytopenia (the dose-limiting toxicity); lymphopenia with PCP risk
  • Pneumocystis jirovecii pneumonia — lymphopenia-driven; mandatory prophylaxis during concurrent phase
  • Hepatotoxicity, including rare reactivation of hepatitis B
  • Severe skin reactions including SJS/TEN (rare)
  • Secondary myelodysplastic syndrome / acute leukaemia (rare, long-term)
  • Severe lymphopenia > 6 months

Warnings

  • Pregnancy: teratogenic. Reliable contraception throughout treatment + 6 months after.
  • Breastfeeding: avoid.
  • Severe hepatic impairment: avoid.
  • Hepatitis B carrier status: screen and consider antiviral prophylaxis — reactivation risk.
  • Live vaccines: contraindicated.
  • Severe lymphopenia / CD4 < 200: continue PCP prophylaxis until lymphocyte recovery.

Drug Interactions

Combine withEffectWhat to do
Live vaccinesDisseminated infectionContraindicated.
Other myelosuppressive drugsAdditive marrow suppressionSpecialist supervision.
Valproic acidMildly reduces temozolomide clearanceNo dose adjustment usually needed.
Co-trimoxazole (PCP prophylaxis)Standard combinationContinue throughout concurrent phase.

Storage

  • Room temperature, 15–30°C, original blister.
  • Out of reach of children, women of childbearing potential, and pets — cytotoxic powder.

Related Alternatives on MedsBase

Other oncology medications stocked alongside this product:

Browse all anti-cancer medications →

Frequently Asked Questions

What is the Stupp protocol?

The Stupp protocol (2005) is the standard combined chemoradiotherapy regimen for newly-diagnosed glioblastoma multiforme: radiotherapy (60 Gy in 30 fractions) + concurrent temozolomide (75 mg/m²/day) for 6 weeks, then 4-week break, then maintenance temozolomide (150–200 mg/m²/day for days 1–5 of each 28-day cycle) for 6 cycles. The protocol extended median survival from 12 to 15 months and remains the global standard in 2026.

Why must I take Temotero on an empty stomach?

Food slows temozolomide absorption and reduces peak plasma concentration. For consistent dosing, take temozolomide at the same time each day with no food for at least 2 hours before. Most patients take it at bedtime ≥ 2 hours after the last meal. Take ondansetron 8 mg orally 1 hour before each dose to prevent nausea.

Why do I need PCP prophylaxis?

The continuous 6-week concurrent phase causes prolonged lymphopenia — particularly low CD4 counts — that creates a real risk of Pneumocystis jirovecii pneumonia (PCP), a potentially fatal opportunistic infection. Standard prophylaxis: co-trimoxazole 480 mg three times weekly throughout concurrent phase, continued until CD4 recovery (often takes 6+ months).

What does “MGMT methylation” mean for my treatment?

MGMT (O6-methylguanine-DNA methyltransferase) is a DNA repair enzyme that undoes temozolomide's alkylation damage. MGMT-methylated tumours have low MGMT expression — they cannot repair the damage, so respond much better to temozolomide. MGMT-unmethylated tumours have high MGMT expression and are relatively temozolomide-resistant. MGMT status is determined on the surgical biopsy and influences treatment intensity (longer maintenance, more aggressive regimens) and prognosis.

What blood tests do I need?

FBC weekly during the concurrent radiotherapy phase. Before each maintenance cycle: FBC on day 22 of the previous cycle and day 1 of the new cycle. LFTs monthly. Hold cycle for ANC < 1,500/µL or platelets < 100,000/µL — thrombocytopenia is the dose-limiting toxicity.

What if I vomit a dose?

If you vomit within 1 hour of taking Temotero, do NOT re-dose — the safety risk of double-dosing is greater than the modest loss of efficacy from one missed dose. Resume the next dose at the scheduled time. Speak to your oncology team about pre-medication adjustment if vomiting recurs.

Can I drink alcohol on Temotero?

Avoid during active treatment. Both alcohol and temozolomide are hepatotoxic, and alcohol increases nausea. Even after treatment finishes, limit alcohol given the hepatic and bone marrow recovery period.

Will Temotero cure my brain tumour?

Glioblastoma multiforme remains one of the most aggressive cancers. The Stupp protocol is the established standard and improves median survival, but cure is uncommon at present. Specific situations carry better prognosis: younger age, MGMT methylation, complete surgical resection, IDH mutation. Discuss prognosis honestly with your neuro-oncologist — treatment goals depend on individual disease characteristics.

Why order from MedsBase

Every batch is sourced from a WHO-GMP certified manufacturer. Orders are dispatched in plain, unbranded packaging from our fulfilment partners and covered by our Reshipment Assurance Policy: if a parcel does not arrive within 20 business days we send a free reshipment, no questions asked.

Related Anti-Cancer Medications

Other oncology medications stocked alongside this product:

More options in Anti Cancer Medication

Ranked by recent MedsBase order volume — what other customers in this category are picking.

Strength

20 mg, 100 mg

Quantity

5 Capsule/s, 10 Capsule/s, 15 Capsule/s, 30 Capsule/s, 60 Capsule/s

Q & A

Ask a question
Temotero Temotero
Your question
* Question is required
Name
* Name is required
There are no questions yet